trending Market Intelligence /marketintelligence/en/news-insights/trending/yI_x-kdK0ir8IivVrLzyPg2 content esgSubNav
In This List

Fate Therapeutics starts common stock offering

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Fate Therapeutics starts common stock offering

Fate Therapeutics Inc. started an underwritten public offering of its common stock.

The net proceeds will be used for clinical development and research activities, working capital and other general corporate purposes.

Leerink Partners LLC and Piper Jaffray & Co. are acting as joint book-running managers for the offering.